Charles Schwab’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Buy |
|
|||||
|
2025
Q1 | $1.82M | Sell |
|
|||||
|
2024
Q4 | $2.21M | Buy |
|
|||||
|
2024
Q3 | $2.18M | Buy |
|
|||||
|
2024
Q2 | $1.98M | Sell |
|
|||||
|
2024
Q1 | $2.47M | Buy |
|
|||||
|
2023
Q4 | $1.78M | Buy |
|
|||||
|
2023
Q3 | $1.75M | Buy |
|
|||||
|
2023
Q2 | $2.15M | Buy |
|
|||||
|
2023
Q1 | $1.76M | Sell |
|
|||||
|
2022
Q4 | $2.72M | Buy |
|
|||||
|
2022
Q3 | $3.15M | Buy |
|
|||||
|
2022
Q2 | $3.04M | Buy |
|
|||||
|
2022
Q1 | $2.99M | Buy |
|
|||||
|
2021
Q4 | $3.53M | Buy |
|
|||||
|
2021
Q3 | $13.8M | Buy |
|
|||||
|
2021
Q2 | $4.22M | Buy |
|
|||||
|
2021
Q1 | $5.49M | Buy |
|
|||||
|
2020
Q4 | $3.61M | Buy |
|